CapEx at other companies
Other financials
Where this comes from
Reported directly by Oruka Therapeutics, Inc. in its filing.
Tagged under the XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment.
The official record: Oruka Therapeutics, Inc.’s 10-Q, filed May 13, 2026, on SEC EDGAR. View the filing →
Ask your AI about Oruka Therapeutics, Inc.'s capex.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Oruka Therapeutics, Inc.'s capex?
- Oruka Therapeutics, Inc. (ORKA) reported capex of $73K in Q1 2026.
- How has Oruka Therapeutics, Inc.'s capex changed year-over-year?
- Oruka Therapeutics, Inc.'s capex increased by 461.5% year-over-year, from $13K to $73K.
- What is the long-term trend for Oruka Therapeutics, Inc.'s capex?
- Over 2 years (2021 to 2025), Oruka Therapeutics, Inc.'s capex has grown at a 120.5% compound annual growth rate (CAGR), from $43K to $209K.
- What does capex mean?
- Cash spent on property, plant, and equipment — the primary measure of investment in productive capacity and infrastructure.